» Authors » Priyanka Jamadagni

Priyanka Jamadagni

Explore the profile of Priyanka Jamadagni including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 34
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sow A, Jamadagni P, Scaturro P, Patten S, Chatel-Chaix L
PLoS Pathog . 2024 Dec; 20(12):e1012756. PMID: 39621753
Infection of pregnant women by Zika virus (ZIKV) is associated with severe neurodevelopmental defects in newborns through poorly defined mechanisms. Here, we established a zebrafish in vivo model of ZIKV...
2.
Breuer M, Rummler M, Singh J, Maher S, Zaouter C, Jamadagni P, et al.
J Bone Miner Res . 2024 Mar; 39(4):498-512. PMID: 38477756
Mutations in the Chromodomain helicase DNA-binding protein 7 - coding gene (CHD7) cause CHARGE syndrome (CS). Although craniofacial and skeletal abnormalities are major features of CS patients, the role of...
3.
Weinschutz Mendes H, Neelakantan U, Liu Y, Fitzpatrick S, Chen T, Wu W, et al.
Cell Rep . 2023 Mar; 42(3):112243. PMID: 36933215
Advancing from gene discovery in autism spectrum disorders (ASDs) to the identification of biologically relevant mechanisms remains a central challenge. Here, we perform parallel in vivo functional analysis of 10...
4.
Jamadagni P, Breuer M, Schmeisser K, Cardinal T, Kassa B, Parker J, et al.
EMBO Rep . 2021 Apr; 22(6):e50958. PMID: 33900016
Mutations in the chromatin remodeller-coding gene CHD7 cause CHARGE syndrome (CS). CS features include moderate to severe neurological and behavioural problems, clinically characterized by intellectual disability, attention-deficit/hyperactivity disorder and autism...
5.
Jamadagni P, Patten S
Neurotoxicology . 2019 Aug; 75:14-23. PMID: 31449834
Oxysterols have essential effects on brain homeostasis and their levels are often altered in neurodegenerative and neuroinflammatory diseases. Several studies have demonstrated the cytotoxic effects of 25-HC on different cell...
6.
Poujol de Molliens M, Jamadagni P, Letourneau M, Devost D, Hebert T, Patten S, et al.
Biochim Biophys Acta Gen Subj . 2019 Jul; 1863(11):129398. PMID: 31306709
Background: The pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1), a class B G protein-coupled receptor (GPCR), has emerged as a promising target for treating neurodegenerative conditions. Unfortunately, despite...